Prostate Cancer Trial, Recruiting NCT06822452 Sponsor: Elsan Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06822452
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men aged 18 or older who have prostate cancer for which a specialist medical team has recommended surgical removal of the prostate (with or without removal of nearby lymph nodes) as a treatment option
  • People who are willing and able to follow all medical instructions given during surgical and anaesthetic appointments
  • People who have access to personal transport so they can return to the hospital or another approved facility if needed
  • People who have access to a telephone or phone communication
  • People who are willing not to drive after the procedure, and who have a responsible adult available to accompany them home and stay with them for the 24 hours following surgery, with that person being informed of the monitoring instructions
  • People who are willing to stay overnight in hospital if the surgical or anaesthetic doctors decide this is necessary
  • People who are covered by, or benefit from, a social security (health insurance) scheme
  • People who have been fully informed about the trial and have given their written consent before any trial-related procedures take place

Who may not be able to join:

  • People who have already received treatment for prostate cancer in the form of brachytherapy (internal radiation seeds), radiotherapy (external radiation), or focal therapy (targeted treatment to part of the prostate)
  • People who are currently taking part in another clinical research study, or who are in a waiting period following a previous study
  • People who are unwilling or unable to follow the study procedures for any reason
  • People who are legally protected adults, such as those under guardianship or curatorship, or people who have had their freedom restricted by a court or government decision

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33556003048

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Elsan
Registry
ClinicalTrials.gov
Start date
30 December 2024
Est. completion
7 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Early complication of robot-assisted prostatectomy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov